Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Budesonide 50micrograms/dose inhaler
0302000K0AAAAAA
|
Budesonide (Inhalation) | Budesonide | Respiratory System | No data available |
|
Buttercup Blackcurrant Flavoured Cough syrup
030902000BEDHA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Buttercup Chesty Cough oral solution
0309020H0BQAAAK
|
Buttercup (Glycerol) | Glycerol | Respiratory System | No data available |
|
Buttercup Original Cough syrup
030902000BECPA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
Buttercup Syrup Honey and Lemon
030902000BECQA0
|
Proprietary compound preparation BNF 0309020 | Other expectorantand demulcent cough preparations | Respiratory System | No data available |
|
C1-esterase inhibitor 1,500unit inj vials
0304030F0AAAEAE
|
C1-Esterase inhibitor | C1-Esterase inhibitor | Respiratory System | No data available |
|
CalCough Children's syrup
0309020H0BMACAI
|
CalCough (Glycerol) | Glycerol | Respiratory System | No data available |
|
Calcough Six Plus 50mg/5ml oral solution
0309020G0BQAAAN
|
Calcough | Guaifenesin | Respiratory System | No data available |
|
CalCough Tickly 750microlitres/5ml oral solution
0309020H0BMAAAH
|
CalCough (Glycerol) | Glycerol | Respiratory System | No data available |
|
Calimal 4mg tablets
0304010G0BEAAAC
|
Calimal | Chlorphenamine maleate | Respiratory System | No data available |
|
CAM Mixture
0301012F0BBAAAL
|
CAM | Ephedrine hydrochloride | Respiratory System | No data available |
|
Camphorated opium tincture
0309020N0AAABAB
|
Opium camph | Powdered opium | Respiratory System | No data available |
|
Carbocisteine 125mg/5ml oral solution
0307000J0AAABAB
|
Carbocisteine | Carbocisteine | Respiratory System | No data available |
|
Care Decongestant 30mg/5ml oral liquid
0310000N0BWAAAF
|
Care (Pseudoephedrine hydrochloride) | Pseudoephedrine hydrochloride | Respiratory System | No data available |
|
Care Hayfever and Allergy oral solution
0304010I0BNAAAB
|
Care | Cetirizine hydrochloride | Respiratory System | No data available |
|
Care Night Time Sleep Aid 25mg tablets
0304010N0BSAAAG
|
Care Sleep Aid | Diphenhydramine hydrochloride | Respiratory System | No data available |
|
Cetec 10mg tablets
0304010I0BJAAAA
|
Cetec | Cetirizine hydrochloride | Respiratory System | No data available |
|
Cetirocol 10mg tablets
0304010I0BDAAAA
|
Cetirocol | Cetirizine hydrochloride | Respiratory System | No data available |
|
Cetor 500unit inj vials
0304030F0BEAAAA
|
Cetor | C1-Esterase inhibitor | Respiratory System | No data available |
|
Chesty Cough Compound of Glycerin, Lemon & Ipecac soln
0309020H0BFACAK
|
Numark Glycerol (Linctus) | Glycerol | Respiratory System | No data available |
|
Chesty Cough Compound of Glycerin, Lemon and Ipecac soln
0309020H0BPACAK
|
Bell's (Glycerol) | Glycerol | Respiratory System | No data available |
|
Children' s Cough Balsam linctus
0309020T0BEAAAG
|
Children's Cough Balsam (Bells) | Ipecacuanha | Respiratory System | No data available |
|
Children's 1 Year Plus Chesty Cough 50mg/5ml syrup
0309020G0BHABAN
|
Boots (Guaifenesin) | Guaifenesin | Respiratory System | No data available |
|
Children's 1 Year Plus Dry Cough 2mg/5ml syrup
0309010X0BNAAAR
|
Boots pholcodine | Pholcodine | Respiratory System | No data available |
|
Children's 6 Month Plus Cough and Congestion syrup
0309020AEBBAAAA
|
Boots (Ephedine/ipecacunha) | Ephedrine hydrochloride/ipecacuanha | Respiratory System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.